BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 979885)

  • 1. [CEA determination in urogenital tract neoplasms].
    Hering H; Weidner W; Hering F
    Med Lab (Stuttg); 1976 Sep; 29(9):193-8. PubMed ID: 979885
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Special problems of early detection of malignant tumors of the genito-urinary system (author's transl)].
    Mebel M; Vogler H
    Arch Geschwulstforsch; 1981; 51(8):679-84. PubMed ID: 6176207
    [No Abstract]   [Full Text] [Related]  

  • 4. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carcinoembryonic antigen test in urologic cancer.
    Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
    Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
    Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CEA test in urologic cancer: an evaluation and a review.
    Guinan P; Dubin A; Bush I; Alsheik H; Ablin RJ
    Oncology; 1975; 32(3-4):158-68. PubMed ID: 1241122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of CEA in urine of patients with bladder carcinoma.
    Persijn JP; Korsten CB; Renaud J
    Z Klin Chem Klin Biochem; 1974 May; 12(5):232. PubMed ID: 4440123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].
    Adolphs HD; Oehr P
    Helv Chir Acta; 1982 Aug; 49(3-4):307-11. PubMed ID: 7129893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic value of urinary enzyme determination in tumors of the urogenital system].
    Dubach UC
    Oncologia; 1965; 19(3):254-8. PubMed ID: 5893379
    [No Abstract]   [Full Text] [Related]  

  • 13. [Childhood urological problems].
    Jakobsen BE
    Ugeskr Laeger; 1969 Jan; 131(2):53-62. PubMed ID: 5767411
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease.
    Fleisher M; Grabstald H; Whitmore WF; Pinsky CM; Oettgen HF; Schwartz MK
    J Urol; 1977 May; 117(5):635-7. PubMed ID: 558345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Elevated CEA values after cystectomy for bladder cancer and intestinal urinary diversion not evidence of tumor recurrence].
    Klippel KF; Axt D; Schärfe T; Preiss J; Alves de Oliveira CR
    Onkologie; 1983 Jun; 6(3):126, 127-31. PubMed ID: 6350964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
    Coombers GB; Hall RR; Laurence JR; Neville AM
    Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
    Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
    Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
    Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exfoliative cytology of the kidney and efferent urinary tract].
    Kirstaedter HJ
    Verh Dtsch Ges Inn Med; 1972; 78():237-43. PubMed ID: 4677219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.